0001127602-15-004354.txt : 20150204 0001127602-15-004354.hdr.sgml : 20150204 20150204165231 ACCESSION NUMBER: 0001127602-15-004354 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150202 FILED AS OF DATE: 20150204 DATE AS OF CHANGE: 20150204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haluska Frank CENTRAL INDEX KEY: 0001494892 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36172 FILM NUMBER: 15576171 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-02-02 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001494892 Haluska Frank C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 SVP, Clinical R&D, CMO Common Stock 2015-02-02 4 M 0 29334 0 A 124633 D Common Stock 2015-02-02 4 S 0 16134 6.3287 D 108499 D Restricted Stock Units 2015-02-02 4 M 0 29334 0 D 2024-01-31 Common Stock 29334 58666 D Shares were acquired upon vesting of restricted stock units awarded on January 31, 2014. Represents shares withheld to satisfy witholding tax requirements, pursuant to a Rule 10b5-1 trading plan. Each restricted stock unit represents a right to receive one share of ARIAD common stock. The restricted stock units vest as to one-third of the units on each of the first, second and third anniversaries of the date of the award (January 31,2014). The restricted stock units vested on January 31, 2015. /s/Edward M. Fitzgerald, Attorney-in-Fact 2015-02-04